Glomerulonephritis during Mycobacterium tuberculosis infection: scoping review.
Glomerulonephritis
Glomerulopathy
Multidrug resistant tuberculosis
Mycobacterium tuberculosis
Nephritic syndrome
Nephrotic syndrome
Journal
BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793
Informations de publication
Date de publication:
31 Aug 2024
31 Aug 2024
Historique:
received:
07
03
2024
accepted:
16
08
2024
medline:
1
9
2024
pubmed:
1
9
2024
entrez:
31
8
2024
Statut:
epublish
Résumé
People with Tuberculosis (TB) infection may present with glomerulonephritis (GN). The range of presentations, renal pathologies, and clinical outcomes are uncertain. Whether clinical features that establish if GN etiology is medication or TB related, and possible benefits of immunosuppression remain uncertain. A scoping review was completed, searching MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, Web of Science and Conference Abstracts from Inception to December, 2023. The study population included patients with TB infection who developed GN and underwent renal biopsy. All data regarding presentation, patient characteristics, renal pathology, management of TB and GN, and outcomes were summarized. There were 62 studies identified, with 130 patients. These cases included a spectrum of presentations including acute kidney injury, nephrotic syndrome and hypertension, and a range of 10 different renal pathology diagnoses. Cases that included immunosuppression and outcomes ranged from complete remission to long-term dialysis dependence. The presence of granulomas (4/4, 100%), anti-glomerular basement membrane disease (3/3, 100%), amyloidosis (75/76, 98.7%), and focal segmental glomerulosclerosis (2/2, 100%) were specific for GN being TB-infection related. On the other hand, minimal change disease was specific for anti-TB therapy related (7/7, 100%). While patients with more aggressive forms of GN commonly were prescribed immunosuppression, this study was unable to confirm efficacy. Only rifampin or isoniazid were implicated in drug-associated GN. This study provides a clear rationale for renal biopsy in patients with TB and GN, and outlines predictors for the GN etiology. Thus, this study establishes key criteria to optimize diagnosis and management of patients with TB and GN.
Identifiants
pubmed: 39217294
doi: 10.1186/s12882-024-03716-6
pii: 10.1186/s12882-024-03716-6
doi:
Substances chimiques
Antitubercular Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
285Informations de copyright
© 2024. The Author(s).
Références
Global Tuberculosis report. World Health Organization. 2023. pp. 1–39.
Organization WH. Tuberculosis. Newsroom fact sheets. World Health Organization; 2023.
Chapagain A, Dobbie H, Sheaff M, Yaqoob MM. Presentation, diagnosis, and treatment outcome of tuberculous-mediated tubulointerstitial nephritis. Kidney Int. 2011;79(6):671–77.
pubmed: 21160461
doi: 10.1038/ki.2010.482
Oxley Oxland J, Ensor J, Freercks R. Tuberculosis and pauci-immune crescentic glomerulonephritis. BMJ Case Rep. 2018;2018.
Griffin SOB, McLaughlin B, Keane AM. J. ANCA associated glomerulonephritis in tuberculosis: a paradoxical reaction. BMJ Case Rep. 2021;14(6).
Kitamura H, Shimizu K, Takeda H, Tai H, Ito Y, Fukunaga M. A case of henoch-schonlein purpura nephritis in pulmonary tuberculosis. Am J Med Sci. 2007;333(2):117–21.
pubmed: 17301592
doi: 10.1097/00000441-200702000-00010
Yuan Q, Sun L, Feng J, Liu N, Jiang Y, Ma J, et al. Lumbar tuberculosis associated with membranous nephropathy and interstitial nephritis. J Clin Microbiol. 2010;48(6):2303–6.
pubmed: 20375238
pmcid: 2884521
doi: 10.1128/JCM.02302-09
Samuel G, Storey D, Singh D, Zhou XJ. Membranoproliferative glomerulonephritis secondary to disseminated tuberculosis after Withdrawal of Adalimumab. Am J Respir Crit Care Med. 2017;195.
Iijima Y, Kobayashi Y, Uchida Y, Tsutsui T, Kakizaki Y, Naganuma T, et al. A case report of granulomatous polyangiitis complicated by tuberculous lymphadenitis. Med (Baltim). 2018;97(43):e12430.
doi: 10.1097/MD.0000000000012430
Morimoto N, Nagahama K, Tsuura Y, Terai A, Tanabe M, Otani M, et al. Membranous nephropathy in a patient with pulmonary tuberculosis infection and lung adenocarcinoma: a case report. CEN Case Rep. 2022;11(1):126–33.
pubmed: 34455551
doi: 10.1007/s13730-021-00641-7
Rodrigues CE, Sette LH, Torritani J, Malheiros DM, Titan SM, Barros RT, et al. Tuberculosis-associated collapsing glomerulopathy: remission after treatment. Ren Fail. 2010;32(1):143–6.
pubmed: 20113281
doi: 10.3109/08860220903368567
Bowman SJ. Pulmonary tuberculosis precipitating the nephrotic syndrome in a patient with sickle cell disease. Nephron. 1991;57(2):236.
pubmed: 2020355
doi: 10.1159/000186259
Cohen AJ, Rosenstein ED. IgA nephropathy associated with disseminated tuberculosis. Arch Intern Med. 1985;145(3):554–6.
pubmed: 3977523
doi: 10.1001/archinte.1985.00360030206036
Rodriguez-Garcia JL, Fraile G, Mampaso F, Teruel JL. Pulmonary tuberculosis associated with membranous nephropathy. Nephron. 1990;55(2):218–9.
pubmed: 2362639
doi: 10.1159/000185957
Rhodes KM. Amyloidosis in Vanuatu. Trans R Soc Trop Med Hyg. 1987;81(2):297–8.
pubmed: 3617194
doi: 10.1016/0035-9203(87)90246-X
Tada T, Ohara A, Nagai Y, Otani M, Ger YC, Kawamura S. A case report of nephrotic syndrome associated with rifampicin therapy. Nihon Jinzo Gakkai Shi. 1995;37(2):145–50.
pubmed: 7752507
Peters M, Godfrey C, McInerney P, Munn Z, Tricco A, Khalil H. Chapter 11: scoping review. In: Aromataris E, editor Manual for evidence synthesis. JBI.
World Bank Country and Lending Groups. In. Bank TW, editor Working for a World Free of Poverty2023.
Pal M, Sengupta M, Basu K, Roychowdhury A. Membranous nephropathy associated with Tuberculosis- a case report. Asian Pac J Trop Med. 2022;15(4):183–85.
doi: 10.4103/1995-7645.340571
Dixit R, Gupta R, Dave L, Prasad N, Sharma S. Clinical profile of patients having pulmonary tuberculosis and renal amyloidosis. Lung India. 2009;26(2):41–5.
pubmed: 20440393
pmcid: 2860413
doi: 10.4103/0970-2113.48896
Engineer DP, Kute VB, Patel HV, Shah PR. Clinical and laboratory profile of renal amyloidosis: a single-center experience. Saudi J Kidney Dis Transpl. 2018 Sep-Oct;29(5):1065–72.
El-Hennawy AS, Goldstein M, Nicastri A. Renal amyloidosis secondary to tuberculosis of cecum. Nephron. 2002;92(3):708–10.
pubmed: 12372961
doi: 10.1159/000064091
Magro-Checa C, Casado ANP, Borrego-Garcia E, Raya-Alvarez E, Rosales-Alexander JL, Salvatierra J, et al. Successful use of Tocilzumab in a patient with nephritic syndrome due to a rapidly progressing AA amlyoidosis secondary to latent tuberculosis. Amyloid- J Protein Fold Disorders. 2011;18:235–39.
doi: 10.3109/13506129.2011.613962
Monsel G, Martinez V, Izzedine H, Mory B, Bricaire F, Caumes E. Anal tuberculosis complicated by secondary amyloidosis. Med Mal Infect. 2011;41(5):264–6.
pubmed: 21420811
doi: 10.1016/j.medmal.2010.12.005
Mandal SK, Sil K, Ganguly J, Chatterjee K, Chatterjee S, Mandal SS. Two cases of nephrotic syndrome with different etiologies. Annals Trop Med Public Health. 2013;6(1):105–08.
doi: 10.4103/1755-6783.115168
Akram A. Tuberculosis-Induced Bronchiectasis complicated by recurrent respiratory tract infections and renal amyloidosis: a Classic Revisited. Cureus. 2020;12(11):e11638.
pubmed: 33376650
pmcid: 7755652
Chugh KS, Datta BN, Singhal PC, Jain SK, Sakhuja V, Dash SC. Pattern of renal amyloidosis in Indian patients. Postgrad Med J. 1981;57(663):31–5.
pubmed: 7279820
pmcid: 2424791
doi: 10.1136/pgmj.57.663.31
Mehta HJ, Talwalkar NC, Merchant MR, Mittal BV, Suratkal LH, Almeida AF, et al. Pattern of renal amyloidosis in western India. A study of 104 cases. J Assoc Physicians India. 1990;38(6):407–10.
pubmed: 2384456
Shah VB, Phatak AM, Shah BS, Kandalkar BM, Haldankar AR, Ranganathan S. Renal amyloidosis–a clinicopathologic study. Indian J Pathol Microbiol. 1996;39(3):179–85.
pubmed: 8972145
Hsieh YP, Wen YK. Anti-glomerular basement membrane glomerulonephritis with subsequent pulmonary hemorrhage in the course of pulmonary tuberculosis. Ren Fail. 2012;34(9):1177–80.
pubmed: 22950833
doi: 10.3109/0886022X.2012.717489
Kashif W, Yaqub S, Mahmood SF, Patel J. Double-positive goodpasture’s syndrome with concomitant active pulmonary tuberculosis. Saudi J Kidney Dis Transpl. 2013;24(4):783–8.
pubmed: 23816731
doi: 10.4103/1319-2442.113886
Wen YK, Wen KI. Pulmonary hemorrhage complicating Goodpasture’s disease in the course of pulmonary tuberculosis. Int Urol Nephrol. 2013;45(6):1773–7.
pubmed: 22826144
doi: 10.1007/s11255-012-0242-9
Murray AN, Cassidy MJ, Templecamp C. Rapidly progressive glomerulonephritis associated with rifampicin therapy for pulmonary tuberculosis. Nephron. 1987;46(4):373–6.
pubmed: 3658067
doi: 10.1159/000184394
O’Brien AA, Kelly P, Gaffney EF, Clancy L, Keogh JA. Immune complex glomerulonephritis secondary to tuberculosis. Ir J Med Sci. 1990;159(6):187.
pubmed: 2146235
doi: 10.1007/BF02937241
Muthukumar T, Jayakumar M, Fernando EM, Muthusethupathi MA. Acute renal failure due to rifampicin: a study of 25 patients. Am J Kidney Dis. 2002;40(4):690–6.
pubmed: 12324902
doi: 10.1053/ajkd.2002.35675
Yoshioka K, Satake N, Kasamatsu Y, Nakamura Y, Shikata N. Rapidly progressive glomerulonephritis due to rifampicin therapy. Nephron. 2002;90(1):116–8.
pubmed: 11744817
doi: 10.1159/000046326
Solak Y, Gaipov A, Anil M, Atalay H, Ozbek O, Turkmen K, et al. Glomerulonephritis associated with tuberculosis: a case report and literature review. Kaohsiung J Med Sci. 2013;29(6):337–42.
pubmed: 23684140
doi: 10.1016/j.kjms.2012.10.008
Kanodia KV, Vanikar AV, Patel RD, Suthar KS, Trivedi HL. Crescentic Glomerulonephritis Associated with Pulmonary Tuberculosis. J Clin Diagn Res. 2016;10(1):ED01–2.
pubmed: 26894074
pmcid: 4740602
Rostami Z, Cegolon L, Jafari NJ, Gholami N, Mousavi SV, Allahyari F, et al. A rare case of coexistence of Wegener’s granulomatosis and pulmonary tuberculosis with subsequent development of thrombosis of the cerebral veins. BMC Infect Dis. 2021;21(1):948.
pubmed: 34521368
pmcid: 8442395
doi: 10.1186/s12879-021-06583-w
Srinivasaprasad ND, Chandramohan G, Praveen V, Fernando ME. Collapsing glomerulopathy associated with pulmonary tuberculosis. Indian J Nephrol. 2016;26(5):373–75.
pubmed: 27795635
pmcid: 5015519
doi: 10.4103/0971-4065.175981
Shribman JH, Eastwood JB, Uff J. Immune complex nephritis complicating miliary tuberculosis. Br Med J (Clin Res Ed). 1983;287(6405):1593–4.
pubmed: 6227368
doi: 10.1136/bmj.287.6405.1593-a
Han BG, Choi SO, Shin SJ, Kim HY, Jung SH, Lee KH. A case of Henoch-Schonlein purpura in disseminated tuberculosis. Korean J Intern Med. 1995;10(1):54–9.
pubmed: 7626558
pmcid: 4532025
doi: 10.3904/kjim.1995.10.1.54
De Siati L, Paroli M, Ferri C, Muda AO, Bruno G, Barnaba V. Immunoglobulin a nephropathy complicating pulmonary tuberculosis. Ann Diagn Pathol. 1999;3(5):300–3.
pubmed: 10556477
doi: 10.1016/S1092-9134(99)80026-4
Matsuzawa N, Nakabayashi K, Nagasawa T, Nakamoto Y. Nephrotic IgA nephropathy associated with disseminated tuberculosis. Clin Nephrol. 2002;57(1):63–8.
pubmed: 11837803
doi: 10.5414/CNP57063
Keven K, Ulger FA, Oztas E, Ergun I, Ekmekci Y, Ensari A, et al. A case of pulmonary tuberculosis associated with IgA nephropathy. Int J Tuberc Lung Dis. 2004;8(10):1274–5.
pubmed: 15527163
Singh P, Khaira A, Sharma A, Dinda AK, Tiwari SC. IgA nephropathy associated with pleuropulmonary tuberculosis. Singap Med J. 2009;50(7):e268–9.
Bueno Filho R, Cordeiro AP, Almeida FT, Shaletich C, Costa RS, Roselino AM. Rare association of cutaneous vasculitis, IgA nephropathy and antiphospholipid antibody syndrome with tuberculous lymphadenitis. Clin (Sao Paulo). 2012;67(12):1497–500.
doi: 10.6061/clinics/2012(12)24
Pradeep I, Anupama SH, Koshy P, Kurien A, Rohit A, Mathew M, et al. A rare association of Mycobacterium tuberculosis infection of kidney and urinary tract with immunoglobulin A nephropathy. Indian J Med Microbiol. 2019 Oct-Dec;37(4):587–89.
Audley G, Davidson B, Jones E, Price B, Rayner B, Wearne N, et al. Disseminated Mycobacterium Tuberculosis and IgA Nephropathy. Case Rep Nephrol. 2022;2022:3785713.
pubmed: 36385747
pmcid: 9643053
Gupta A, Khaira A. Immunotactoid glomerulopathy and tuberculosis: a novel association. Nefrologia. 2011;31(3):369–71.
pubmed: 21629347
Meyrier A, Valensi P, Sebaoun J. Mesangio-capillary glomerulonephritis and the nephrotic syndrome in the course of disseminated tuberculosis. Nephron. 1988;49(4):341–2.
pubmed: 3412551
doi: 10.1159/000185091
Kistler A, Lappin DW, Coward RA. Therapeutic dilemma: crescentic mesangiocapillary glomerulonephritis type 1 in a patient on antituberculous therapy with rifampicin. Nephrol Dial Transpl. 1999;14(1):243–4.
doi: 10.1093/ndt/14.1.243
Ram R, Sandeep P, Sridhar AV, Rukumangadha N, Sivakumar V. Membranoproliferative glomerulonephritis and Pott’s disease. Clin Kidney J. 2014;7(4):391–3.
pubmed: 25852915
pmcid: 4377797
doi: 10.1093/ckj/sfu051
Helvaci O, Erten Y, Gonul I, Ozet A, Hazneda R. Tuberculosis presenting as proliferative glomerulonephritis with monoclonal immunoglobulin deposits. Revista De Nefrologia Dialisis y Transplante. 2021;41(3):202–06.
Gabow PA, Lacher JW, Neff TA. Tubulointerstitial and glomerular nephritis associated with rifampin. Report of a case. JAMA. 1976;235(23k0):2517–8.
pubmed: 946666
doi: 10.1001/jama.1976.03260490035017
Suzuki Y, Hasegawa H, Ushiyama E, Inomata A, Satoh H, Ogino S, et al. [A case of nephrotic syndrome with membranous nephropathy and renal tuberculous granuloma]. Nihon Naika Gakkai Zasshi. 1989;78(8):1181–6.
pubmed: 2809389
doi: 10.2169/naika.78.1181
Ghosh B, Pande A, Ghosh A, Banerjee A, Saha S. Membranous glomerulonephritis and tuberculous peritonitis: a rare association. J Infect Dev Ctries. 2011;5(7):550–2.
pubmed: 21795825
doi: 10.3855/jidc.1548
Ram R, Swarnalatha G, Desai M, Rakesh Y, Uppin M, Prayaga A, et al. Membranous nephropathy and granulomatous interstitial nephritis due to tuberculosis. Clin Nephrol. 2011;76(6):487–91.
pubmed: 22105453
doi: 10.5414/CN106678
Malhotra KP, Chandra A, Rao N, Shukla S, Gupta A. Tuberculosis as a microbiologically proven etiology of membranous nephropathy and interstitial nephritis. Saudi J Kidney Dis Transpl. 2019 Nov-Dec;30(6):1447–49.
Balwani MR, Pasari AS, Bhawane A, Tolani P. Anti-phospholipase A2 Receptor Antibody-Positive Membranous Glomerulopathy due to Anti-Koch’s Therapy in a Tuberculosis Patient. Saudi J Kidney Dis Transpl. 2021 Nov-Dec;32(6):1800–03.
Neugarten J, Gallo GR, Baldwin DS. Rifampin-induced nephrotic syndrome and acute interstitial nephritis. Am J Nephrol. 1983 Jan-Feb;3(1):38–42.
Barnes N, Bellamy D, Ireland R, Parsons V, Costello J. Pulmonary tuberculosis complicated by haemophagocytic syndrome and rifampicin-induced tubulointerstitial nephritis. Br J Dis Chest. 1984;78(4):395–403.
pubmed: 6487531
doi: 10.1016/0007-0971(84)90175-X
Mori S, Matsushita Y, Arizono K. Minimal-change nephrotic syndrome associated with isoniazid in anti-tuberculosis chemoprophylaxis for a patient with rheumatoid arthritis. Intern Med. 2011;50(3):253–7.
pubmed: 21297330
doi: 10.2169/internalmedicine.50.4346
Park DH, Lee SA, Jeong HJ, Yoo TH, Kang SW, Oh HJ. Rifampicin-induced minimal change disease is improved after cessation of rifampicin without steroid therapy. Yonsei Med J. 2015;56(2):582–5.
pubmed: 25684013
pmcid: 4329376
doi: 10.3349/ymj.2015.56.2.582
Kim JS, Kim KJ, Choi EY. Minimal change disease related to rifampicin presenting with acute renal failure during treatment for latent tuberculosis infection: a case report. Med (Baltim). 2018;97(22):e10556.
doi: 10.1097/MD.0000000000010556
Sathi S, Garg AK, Singh MK, Saini VS, Vohra D. Rifampicin-Associated secondary minimal change Disease presenting with nephrotic syndrome in a pulmonary tuberculosis patient. Case Rep Nephrol. 2021;2021:5546942.
pubmed: 33936823
pmcid: 8060098
Sopena B, Sobrado J, Javier Perez A, Oliver J, Courel M, Palomares L, et al. Rapidly progressive glomerulonephritis and pulmonary tuberculosis. Nephron. 1991;57(2):251–2.
pubmed: 2020362
doi: 10.1159/000186268
Isotalo PA, Ford JC, Veinot JP. Diffuse glomerulonephritis associated with rifampin treatment for tuberculosis. Pathology. 2002;34(3):295–97.
Yong JL, Killingsworth MC. Diffuse glomerulonephritis associated with rifampicin treatment for tuberculosis. Pathology. 2002;34(3):295–7.
pubmed: 12109797
doi: 10.1080/00313020212468
Asim M, Akhtar M. Epidemiology, impact, and management strategies of anti-glomerular basement membrane disease. Int J Nephrol Renovasc Dis. 2022;15:129–38.
pubmed: 35418771
pmcid: 8999706
doi: 10.2147/IJNRD.S326427
Nyang’wa BT, Berry C, Kazounis E, Motta I, Parpieva N, Tigay Z, et al. A 24-Week, all-oral regimen for Rifampin-resistant tuberculosis. N Engl J Med. 2022;387(25):2331–43.
pubmed: 36546625
doi: 10.1056/NEJMoa2117166
Dai H, Zhang H, He Y. Diagnostic accuracy of PLA2R autoantibodies and glomerular staining for the differentiation of idiopathic and secondary membranous nephropathy: an updated meta-analysis. Sci Rep. 2015;5:8803.
pubmed: 25740009
pmcid: 4350087
doi: 10.1038/srep08803
Smith KD, Alpers CE. Pathogenic mechanisms in membranoproliferative glomerulonephritis. Curr Opin Nephrol Hypertens. 2005;14(4):396–403.
pubmed: 15931011
doi: 10.1097/01.mnh.0000172729.60122.f9
Perez-Noriega FA, Salinas-Lara C, Sanchez-Garibay C, Torres-Ruiz JJ, Maravillas-Montero JL, Castanon-Arreola M et al. Mycobacterium tuberculosis Cell Wall Antigens induce the formation of Immune complexes and the development of Vasculitis in an experimental murine model. Int J Mol Sci. 2023;24(2).
Ogata H, Kubo M, Tamaki K, Hirakata H, Okuda S, Fujishima M. Crescentic glomerulonephritis due to rifampin treatment in a patient with pulmonary atypical mycobacteriosis. Nephron. 1998;78(3):319–22.
pubmed: 9546693
doi: 10.1159/000044942
Bassi L, Pernal G, Silvestri L. Antibodies against rifampicin in patients with tuberculosis after discontinuation of daily treatment. Am Rev Respir Dis. 1976;114:1189–90.
Glassock RJ. Secondary minimal change disease. Nephrol Dial Transpl. 2003;18(Suppl 6):vi52–8.
Tan CD, Smith A, Rodriguez ER. Systemic necrotizing vasculitis induced by isoniazid. Cardiovasc Pathol 2014 May-Jun;23(3):181–2.